166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo

Rachel Burga; Mithun Khattar; Scott Lajoie; Kyle Pedro; Colleen Foley; Alonso Villasmil Ocando; Jack Tremblay; Benjamin Primack; Meghan Langley; Dan Thornton; Stanley Tam; Emily Brideau; Theresa Ross; Gwen Wilmes; Sunandan Saha; Gabriel Helmlinger; Jeremy Tchaicha; Dhruv Sethi; Michelle Ols; Gary Vanasse; Shyam Subramanian; Jan ter Meulen

doi:10.1136/jitc-2021-SITC2021.166

Citation Tools

Regular and Young Investigator Award Abstracts

Cellular Therapies

166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Burga R, Khattar M, Lajoie S, et al

166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.166

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password